Friday, August 14, 2026

SBE303: The Next-Gen ADC Cancer Drug Revolutionizing Treatment in 2026

Samsung Bioepis presents promising results for SBE303, a next-gen ADC targeting nectin-4, showing improved efficacy and safety in trials.

Coupang Under Fire: Are Korean Regulations Targeting U.S. Companies Unfair?

U.S. Congress claims South Korea unfairly discriminates against American companies like Coupang amid large data breach sanctions.

Hanwha Defense USA partners with Magnet to co-develop unmanned surface vessel for U.S. military

Hanwha Defense USA partners with Magnet Defense to develop medium unmanned surface vessels for the U.S. military, enhancing maritime capabilities.

Tag: generics

North KoreaKoreaKimMilitaryAISouth Koreamarketrelationsdevelopment

How the 2026 Drug Price Reform Will Reshape the Pharmaceutical Industry

Experts discuss the impact of drug pricing reform on the pharmaceutical sector, urging innovation and strategic shifts in R&D investments.

Can Samjin Pharm Overcome Generic Drug Price Cuts With AI-Driven Drug Development?

Samjin Pharm shifts focus to R&D, moving away from generics to innovative drug development, amid government price cuts.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.